attached in position 6

Industry

CPC
C07D473/30

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07DHETEROCYCLIC COMPOUNDS C07D473/00Heterocyclic compounds containing purine ring systems

Current Industry

C07D473/30attached in position 6

Industries

Patents Grantslast 30 patents

Information Patent Grant
Caffeine inhibitors of MTHFD2 and uses thereof
- Patent number 12,187,728
- Issue date Jan 7, 2025
- Raze Therapeutics, Inc.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of cancer and inflammatory disease
- Patent number 12,168,668
- Issue date Dec 17, 2024
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of stimulator of interferon genes (STING)
- Patent number 12,162,863
- Issue date Dec 10, 2024
- RYVU THERAPEUTICS S.A.
- Monika Patrycja Dobrzanska
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hypoxanthine compounds
- Patent number 12,157,739
- Issue date Dec 3, 2024
- KISSEI PHARMACEUTICAL CO., LTD.
- Yasushi Takigawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nitrogen activator stabilizer for reducing and protecting nitrogen...
- Patent number 12,006,272
- Issue date Jun 11, 2024
- KING FAISAL UNIVERSITY
- Hossam El-Din Saad El-Beltagi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nitrogen activator stabilizer for reducing and protecting nitrogen...
- Patent number 11,999,669
- Issue date Jun 4, 2024
- KING FAISAL UNIVERSITY
- Hossam El-Din Saad El-Beltagi
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Specific synthetic chimeric xenonucleic acid guide RNA; s(XNA-gRNA)...
- Patent number 11,845,934
- Issue date Dec 19, 2023
- DiaCarta Inc.
- Michael J Powell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Type II raf kinase inhibitors
- Patent number 11,826,365
- Issue date Nov 28, 2023
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxadiazole transient receptor potential channel inhibitors
- Patent number 11,655,245
- Issue date May 23, 2023
- Genentech, Inc.
- Jack Alexander Terrett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of cancer and inflammatory disease
- Patent number 11,560,390
- Issue date Jan 24, 2023
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives for use as medicament and for use in treating ne...
- Patent number 11,472,807
- Issue date Oct 18, 2022
- Commissariat a l'Energie Atomique et Aux Energies Alternatives
- Aloïse Mabondzo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxyl purine compounds and applications thereof
- Patent number RE49128
- Issue date Jul 12, 2022
- GUANGDONG RAYNOVENT BIOTECH CO., LTD.
- Lingyun Wu
Information Patent Grant
Caffeine inhibitors of MTHFD2 and uses thereof
- Patent number 11,370,792
- Issue date Jun 28, 2022
- RAZE THERAPEUTICS, INC.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aryl ether compound, preparation method thereof, pharma...
- Patent number 11,319,322
- Issue date May 3, 2022
- Xiamen University
- Xianming Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds targeting PRMT5
- Patent number 11,198,699
- Issue date Dec 14, 2021
- Aligos Therapeutics, Inc.
- Koen Vandyck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused hetero-hetero bicyclic compounds and methods of use thereof
- Patent number 11,059,819
- Issue date Jul 13, 2021
- Janssen Biotech, Inc.
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Certain chemical entities, compositions, and methods
- Patent number 10,947,201
- Issue date Mar 16, 2021
- NeuPharma, Inc.
- Xiangping Qian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazolones as transient receptor potential channel inhibitors
- Patent number 10,913,742
- Issue date Feb 9, 2021
- Genentech, Inc.
- Huifen Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of cancer and inflammatory disease
- Patent number 10,870,657
- Issue date Dec 22, 2020
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enantiomers of the 1′,6′-isomer of neplanocin A
- Patent number 10,787,478
- Issue date Sep 29, 2020
- Auburn University
- Stewart W. Schneller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazole transient receptor potential channel inhibitors
- Patent number 10,710,994
- Issue date Jul 14, 2020
- Genentech, Inc.
- Jack Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxadiazole transient receptor potential channel inhibitors
- Patent number 10,711,004
- Issue date Jul 14, 2020
- Genentech, Inc.
- Huifen Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of human phosphatidylinositol 3-kinase delta
- Patent number 10,695,349
- Issue date Jun 30, 2020
- ICOS Corporation
- Chanchal Sadhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Urea compound, preparation method therefor and medical use thereof
- Patent number 10,647,680
- Issue date May 12, 2020
- Ancureall Pharmaceutical (Shanghai) Co., Ltd.
- Jutong Si
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ice nucleation activator
- Patent number 10,633,570
- Issue date Apr 28, 2020
- THE SCHOOL CORPORATION KANSAI UNIVERSITY
- Hidehisa Kawahara
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Fused tricyclic compounds as Raf kinase inhibitors
- Patent number 10,576,087
- Issue date Mar 3, 2020
- BeiGene, Ltd.
- Changyou Zhou
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dime...
- Patent number 10,562,899
- Issue date Feb 18, 2020
- BeiGene, Ltd.
- Changyou Zhou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds as modulators of a mutant CFTR protein and their use for...
- Patent number 10,463,639
- Issue date Nov 5, 2019
- INSTYTUT BIOCHEMII I BIOFIZYKI PAN
- Norbert Odolczyk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as modulators of a mutant CFTR protein and their use for...
- Patent number 10,420,738
- Issue date Sep 24, 2019
- Instytut Biochemii I Biofizyki Pan
- Norbert Odolczyk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as modulators of a mutant CFTR protein and their use for...
- Patent number 10,398,665
- Issue date Sep 3, 2019
- Instytut Biochemii I Biofizyki Pan
- Norbert Odolczyk
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
POLQ INHIBITORS
- Publication number 20240366615
- Publication date Nov 7, 2024
- AstraZeneca AB
- BERNARD BARLAAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PURINE DERIVATIVES AS ANTICANCER AGENTS
- Publication number 20240059689
- Publication date Feb 22, 2024
- Tango Therapeutics, Inc.
- Scott Throner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION
- Publication number 20230357168
- Publication date Nov 9, 2023
- The Chinese University of Hong Kong
- Wai-Lung NG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the Treatment of Cancer and Inflammatory Disease
- Publication number 20230286997
- Publication date Sep 14, 2023
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS
- Publication number 20230121700
- Publication date Apr 20, 2023
- Genentech, Inc.
- Jack Alexander TERRETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF
- Publication number 20230067237
- Publication date Mar 2, 2023
- Raze Therapeutics, Inc.
- Nello Mainolfi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)
- Publication number 20220402898
- Publication date Dec 22, 2022
- RYVU THERAPEUTICS S.A.
- Monika Patrycja DOBRZANSKA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE
- Publication number 20220332725
- Publication date Oct 20, 2022
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AROMATIC COMPOUNDS FOR USE IN ACTIVATING HEMATOPOIETIC STEM AND PRO...
- Publication number 20220251104
- Publication date Aug 11, 2022
- Celularity Inc.
- Robert J. HARIRI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF
- Publication number 20220162209
- Publication date May 26, 2022
- Memorial Sloan-Kettering Cancer Center
- Derek Shieh Tan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS TARGETING PRMT5
- Publication number 20220048922
- Publication date Feb 17, 2022
- ALIGOS THERAPEUTICS, INC.
- Koen Vandyck
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Com...
- Publication number 20220024925
- Publication date Jan 27, 2022
- Acurx Pharmaceuticals LLC
- Xiang Y. YU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HYPOXANTHINE COMPOUNDS
- Publication number 20210214357
- Publication date Jul 15, 2021
- Kissei Pharmaceutical Co., Ltd.
- Yasushi Takigawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THE...
- Publication number 20210177758
- Publication date Jun 17, 2021
- THEAPRIN PHARMACEUTICALS, INC.
- Harry G. BRITTAIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
- Publication number 20210163423
- Publication date Jun 3, 2021
- NeuPharma, Inc.
- Xiangping Qian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PURINE DERIVATIVES FOR USE AS MEDICAMENT AND FOR USE IN TREATING NE...
- Publication number 20200354364
- Publication date Nov 12, 2020
- Commissariat A L'Energie Atomique et Aux Energies Alternatives
- Aloïse MABONDZO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS
- Publication number 20200308161
- Publication date Oct 1, 2020
- Genentech, Inc.
- Jack Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TYPE II RAF KINASE INHIBITORS
- Publication number 20200297721
- Publication date Sep 24, 2020
- Dana-Farber Cancer Institute, Inc.
- Nathanael S. Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMA...
- Publication number 20200123162
- Publication date Apr 23, 2020
- XIAMEN UNIVERSITY
- Xianming Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
- Publication number 20200061062
- Publication date Feb 27, 2020
- ICOS CORPORATION
- Chanchal SADHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AND THEIR USES
- Publication number 20200048265
- Publication date Feb 13, 2020
- Amgen Inc.
- Yi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS
- Publication number 20200002340
- Publication date Jan 2, 2020
- Genentech, Inc.
- Huifen CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETERO-HETERO BICYCLIC COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20190345158
- Publication date Nov 14, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC SYNTHETIC CHIMERIC XENONUCLEIC ACID GUIDE RNA; s(XNA-gRNA)...
- Publication number 20190330621
- Publication date Oct 31, 2019
- Michael J Powell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OXADIAZOLONES AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS
- Publication number 20190284189
- Publication date Sep 19, 2019
- Genentech, Inc.
- Huifen CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS
- Publication number 20190284179
- Publication date Sep 19, 2019
- Genentech, Inc.
- Jack Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
- Publication number 20190255194
- Publication date Aug 22, 2019
- ModernaTX, Inc.
- Atanu ROY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMTORY DISEASE
- Publication number 20190218229
- Publication date Jul 18, 2019
- SHY Therapeutics LLC
- Yaron R. Hadari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A
- Publication number 20190202854
- Publication date Jul 4, 2019
- Auburn University
- Stewart W. Schneller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED TRICYCLIC UREA COMPOUNDS AS RAF KINASE AND/OR RAF KINASE DIME...
- Publication number 20190144446
- Publication date May 16, 2019
- BeiGene, Ltd.
- Changyou Zhou
- C07 - ORGANIC CHEMISTRY

attached in position 6

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Caffeine inhibitors of MTHFD2 and uses thereof

Compounds for the treatment of cancer and inflammatory disease

Modulators of stimulator of interferon genes (STING)

Hypoxanthine compounds

Nitrogen activator stabilizer for reducing and protecting nitrogen...

Nitrogen activator stabilizer for reducing and protecting nitrogen...

Specific synthetic chimeric xenonucleic acid guide RNA; s(XNA-gRNA)...

Type II raf kinase inhibitors

Oxadiazole transient receptor potential channel inhibitors

Compounds for the treatment of cancer and inflammatory disease

Purine derivatives for use as medicament and for use in treating ne...

Hydroxyl purine compounds and applications thereof

Caffeine inhibitors of MTHFD2 and uses thereof

Substituted aryl ether compound, preparation method thereof, pharma...

Compounds targeting PRMT5

Fused hetero-hetero bicyclic compounds and methods of use thereof

Certain chemical entities, compositions, and methods

Oxadiazolones as transient receptor potential channel inhibitors

Compounds for the treatment of cancer and inflammatory disease

Enantiomers of the 1′,6′-isomer of neplanocin A

Oxadiazole transient receptor potential channel inhibitors

Oxadiazole transient receptor potential channel inhibitors

Inhibitors of human phosphatidylinositol 3-kinase delta

Urea compound, preparation method therefor and medical use thereof

Anti-ice nucleation activator

Fused tricyclic compounds as Raf kinase inhibitors

Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dime...

Compounds as modulators of a mutant CFTR protein and their use for...

Compounds as modulators of a mutant CFTR protein and their use for...

Compounds as modulators of a mutant CFTR protein and their use for...

Patents Applicationslast 30 patents

POLQ INHIBITORS

PURINE DERIVATIVES AS ANTICANCER AGENTS

CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION

Compounds for the Treatment of Cancer and Inflammatory Disease

OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF

MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)

COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE

AROMATIC COMPOUNDS FOR USE IN ACTIVATING HEMATOPOIETIC STEM AND PRO...

SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF

COMPOUNDS TARGETING PRMT5

Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Com...

HYPOXANTHINE COMPOUNDS

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THE...

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

PURINE DERIVATIVES FOR USE AS MEDICAMENT AND FOR USE IN TREATING NE...

OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

TYPE II RAF KINASE INHIBITORS

SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMA...

INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA

HETEROCYCLIC COMPOUNDS AND THEIR USES

OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

FUSED HETERO-HETERO BICYCLIC COMPOUNDS AND METHODS OF USE THEREOF

SPECIFIC SYNTHETIC CHIMERIC XENONUCLEIC ACID GUIDE RNA; s(XNA-gRNA)...

OXADIAZOLONES AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF

COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMTORY DISEASE

ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A

FUSED TRICYCLIC UREA COMPOUNDS AS RAF KINASE AND/OR RAF KINASE DIME...